Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/18 | 860 | 910 | 841 | 857 | +12 | +1.4% | 39,300 |
2020/03/17 | 746 | 860 | 726 | 845 | +84 | +11% | 101,300 |
2020/03/16 | 753 | 848 | 733 | 761 | +23 | +3.1% | 68,700 |
2020/03/13 | 763 | 784 | 707 | 738 | -119 | -13.9% | 117,500 |
2020/03/12 | 888 | 905 | 813 | 857 | -1 | -0.1% | 54,300 |
2020/03/11 | 950 | 985 | 856 | 858 | -102 | -10.6% | 46,300 |
2020/03/10 | 900 | 960 | 826 | 960 | +37 | +4% | 100,000 |
2020/03/09 | 1,000 | 1,007 | 913 | 923 | -117 | -11.3% | 50,700 |
2020/03/06 | 1,135 | 1,143 | 1,016 | 1,040 | -133 | -11.3% | 80,800 |
2020/03/05 | 1,086 | 1,231 | 1,066 | 1,173 | +117 | +11.1% | 88,000 |
2020/03/04 | 964 | 1,079 | 964 | 1,056 | +62 | +6.2% | 36,900 |
2020/03/03 | 1,100 | 1,109 | 992 | 994 | -63 | -6% | 71,100 |
2020/03/02 | 1,005 | 1,115 | 988 | 1,057 | +47 | +4.7% | 125,400 |
2020/02/28 | 1,039 | 1,090 | 999 | 1,010 | -89 | -8.1% | 74,100 |
2020/02/27 | 1,150 | 1,150 | 1,044 | 1,099 | -32 | -2.8% | 85,600 |
2020/02/26 | 1,165 | 1,180 | 1,119 | 1,131 | -64 | -5.4% | 34,800 |
2020/02/25 | 1,200 | 1,249 | 1,177 | 1,195 | -100 | -7.7% | 67,100 |
2020/02/21 | 1,289 | 1,321 | 1,282 | 1,295 | +6 | +0.5% | 28,600 |
2020/02/20 | 1,360 | 1,360 | 1,288 | 1,289 | -17 | -1.3% | 28,400 |
2020/02/19 | 1,285 | 1,376 | 1,285 | 1,306 | -9 | -0.7% | 62,100 |
2020/02/18 | 1,402 | 1,403 | 1,301 | 1,315 | -97 | -6.9% | 62,100 |
2020/02/17 | 1,433 | 1,472 | 1,412 | 1,412 | -64 | -4.3% | 36,900 |
2020/02/14 | 1,528 | 1,558 | 1,465 | 1,476 | -84 | -5.4% | 41,000 |
2020/02/13 | 1,570 | 1,570 | 1,554 | 1,560 | -23 | -1.5% | 6,900 |
2020/02/12 | 1,586 | 1,587 | 1,530 | 1,583 | +29 | +1.9% | 31,600 |
2020/02/10 | 1,520 | 1,653 | 1,473 | 1,554 | +37 | +2.4% | 98,100 |
2020/02/07 | 1,448 | 1,520 | 1,445 | 1,517 | +77 | +5.3% | 55,900 |
2020/02/06 | 1,449 | 1,449 | 1,430 | 1,440 | +2 | +0.1% | 18,500 |
2020/02/05 | 1,435 | 1,450 | 1,417 | 1,438 | +18 | +1.3% | 19,100 |
2020/02/04 | 1,420 | 1,424 | 1,400 | 1,420 | ±0 | ±0% | 23,000 |
2020/02/03 | 1,400 | 1,430 | 1,393 | 1,420 | -37 | -2.5% | 47,500 |
2020/01/31 | 1,455 | 1,502 | 1,438 | 1,457 | -20 | -1.4% | 32,800 |
2020/01/30 | 1,500 | 1,513 | 1,440 | 1,477 | -41 | -2.7% | 48,800 |
2020/01/29 | 1,519 | 1,520 | 1,490 | 1,518 | -1 | -0.1% | 24,600 |
2020/01/28 | 1,451 | 1,534 | 1,450 | 1,519 | +48 | +3.3% | 42,500 |
2020/01/27 | 1,500 | 1,500 | 1,466 | 1,471 | -29 | -1.9% | 33,200 |
2020/01/24 | 1,500 | 1,506 | 1,493 | 1,500 | -5 | -0.3% | 18,300 |
2020/01/23 | 1,515 | 1,518 | 1,495 | 1,505 | -14 | -0.9% | 17,600 |
2020/01/22 | 1,520 | 1,528 | 1,515 | 1,519 | -9 | -0.6% | 29,100 |
2020/01/21 | 1,525 | 1,532 | 1,517 | 1,528 | -2 | -0.1% | 12,200 |
2020/01/20 | 1,539 | 1,539 | 1,522 | 1,530 | -4 | -0.3% | 11,700 |
2020/01/17 | 1,550 | 1,552 | 1,522 | 1,534 | -17 | -1.1% | 15,600 |
2020/01/16 | 1,554 | 1,556 | 1,537 | 1,551 | -8 | -0.5% | 12,500 |
2020/01/15 | 1,560 | 1,561 | 1,535 | 1,559 | +4 | +0.3% | 9,000 |
2020/01/14 | 1,570 | 1,570 | 1,516 | 1,555 | +4 | +0.3% | 27,900 |
2020/01/10 | 1,601 | 1,601 | 1,536 | 1,551 | -42 | -2.6% | 27,000 |
2020/01/09 | 1,600 | 1,601 | 1,580 | 1,593 | +17 | +1.1% | 16,800 |
2020/01/08 | 1,664 | 1,676 | 1,464 | 1,576 | -105 | -6.2% | 119,200 |
2020/01/07 | 1,688 | 1,700 | 1,670 | 1,681 | -7 | -0.4% | 10,400 |
2020/01/06 | 1,720 | 1,721 | 1,673 | 1,688 | -41 | -2.4% | 26,400 |
1301~
1350
件表示中 / 1645件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 73,900円 | - | - | 0.00% | - | 29.36倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
ケイファーマ | 73,100円 | - | - | 0.00% | - | 3.76倍 |
|
慶応大学発ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
PRISMBio | 22,900円 | +14.8% | - | 0.00% | - | 2.75倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
OTS | 2,900円 | +33.3% | - | 0.00% | - | 12.24倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
ティムス | 17,500円 | - | - | 0.00% | - | 2.81倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国CORXEL社に導出 |
市場注目の銘柄
チャート関連のコラム